-
Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication
-
Molecular characterization of the A52 murine hepatocellular carcinoma cell line
-
Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model
-
Identification of senescence‐related genes in Parkinson's disease reveals candidate therapeutic targets and pathological processes
-
Tree shrew model of early diabetic retinopathy reveals microvascular dysfunction and identifies phosphoserine aminotransferase 1 as a novel therapeutic target
-
A story of targeted drug delivery formulation of Genistein and Chitosan combination opening doors to healing potential
-
Exploratory Review on Male Fertility Potential of Acetyl-Eugenol: Mechanistic Insights, Experimental Evidence, and Therapeutic Prospects
-
Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosis
-
Association Between Multi‐Laboratory Parameters Pre‐ and Post‐Treatment and Pathological Features and Their Values in Clinical Decision in Primary Hepatic Carcinoma
-
Serum Lipids, Insulin-Like Growth Factor Binding Protein-3 and Treatment Outcomes in Women with and without Cervical Lesions in South Western Uganda: A Cohort Study
-
Measurement of Active Thrombin Bound to Circulating D‐Dimers as a Sensitive Biomarker for Prothrombotic Conditions
-
RETRACTION: Katanin P80 as a Prognostic Biomarker Associated With Tumor Progression in Non–Small‐Cell Lung Cancer
-
Soluble B7‐H6 as a Novel Diagnostic Biomarker for Post‐Hepatitis B Cirrhosis: A Clinical Value Study
-
Assessment of Dried Plasma Spots (DPS) as an Appropriate Sample Matrix for the Measurement of Circulating Calretinin, a Biomarker for Mesothelioma—A Proof‐Of‐Concept Study
-
Bicontinuous Cubic Phase Lipid Nanoparticles Cubosomes: Formulation, Characterization, and Therapeutic Applications
-
Hantavirus Infections: Emerging Epidemiological and Therapeutic Challenges, Epidemiology, Pathogenesis, Diagnosis and Management
-
Nuclear factor of activated T cells as a driver of tumor progression and a target for precision therapy
-
Mom Asli (Beeswax): A Review of Its Unani Perspective, Pharmacological Actions, Therapeutic Uses, and Scientific Studies
-
Advancement in Green nano-formulation for management of Gynaecological disorders: Emerging trends and Therapeutic insights
-
Organ‐Specific Human Microbiomes and Dysbiosis: Mechanistic Links to Disease and Emerging Therapeutic Strategies
-
Systemic lupus erythematosus and early-onset preeclampsia during pregnancy: Clinical challenges and therapeutic approach—A case report
-
Nanocarriers for Brain Targeting: Overcoming the Blood-Brain Barrier in Neuropharmacology
-
Exosome‐mediated gut–brain axis signaling in neurodegenerative diseases: Mechanisms, experimental evidence, and therapeutic perspectives—A narrative review
-
Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study
